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Abstract 
Background and Significance: Selecting cohorts for a clinical trial typically requires costly and 
time-consuming manual chart reviews resulting in poor participation. To help automate the 
process, National NLP Clinical Challenges (N2C2) conducted a shared challenge by defining 13 
criteria for clinical trial cohort selection and by providing training and test datasets. This research 
was motivated by the N2C2 challenge. 
Methods: We broke down the task into 13 independent subtasks corresponding to each criterion 
and implemented subtasks using rules or a supervised machine learning model. Each task 
critically depended on knowledge resources in the form of task-specific lexicons, for which we 
developed a novel model-driven approach. The approach allowed us to first expand the lexicon 
from a seed set and then remove noise from the list, thus improving the accuracy. 
Results: Our system achieved an overall F measure of 0.9003 at the challenge, and was 
statistically tied for the first place out of 45 participants. The model-driven lexicon development 
and further debugging the rules/code on the training set improved overall F measure to 0.9140, 
overtaking the best numerical result at the challenge.  
Discussion: Cohort selection, like phenotype extraction and classification, is amenable to rule-
based or simple machine learning methods, however, the lexicons involved – such as medication 
names or medical terms referring to a medical problem – critically determine the overall 
accuracy. Automated lexicon development has the potential for scalability and accuracy. 
Background and Significance 
Participation in clinical trials is alarmingly low, even though they are a vital part of medical 
research for developing new methods, drugs, and instruments for prevention, diagnosis, 
screening, treatment, and quality of life improvement.  A 2010 study by the US Institute of 
Medicine [1] observed that only about 3% of adult cancer patients participate in clinical trials, 
and 40% of trials failed to achieve minimum patient enrollment. This is, in part, because clinical 
trials often have complex criteria that cannot be simply assessed using a database query on the 
structured (coded) part of a patient’s record. It requires a careful review of the clinical narratives 
in a patient’s record. It is a time-consuming process requiring advanced medical training, and so 
often researchers are limited to patients who either seek out the trials or who have been referred 
by their physicians. 
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Using researchers’ familiarity or referrals alone can result in selection bias towards certain 
populations (e.g. people who can afford regular care or people who exclusively use free clinics), 
which in turn can bias the results of the study [2][3]. Indeed, there are many studies that point 
out lack of trials participation from minority groups and rural areas. An automated analysis of 
clinical notes, which can be eventually included in EHR systems, can reduce the time and cost it 
takes to identify patients, and can potentially help remove the biases in participant selection. 
Due to the potential complexity of the selection criteria there is a need for advanced natural 
language processing methods for such an automated selection. 
 
National NLP Clinical Challenges (N2C2), which has evolved from the well-known i2b2 
(Informatics for Integrating Biology and the Bedside) NLP Shared Task challenges, has organized 
a shared challenge to address the question “Can NLP systems use narrative medical records to 
identify which patients meet selection criteria for clinical trials?” [4]. The task required NLP 
systems to determine if each patient meets a specific list of 13 selection criteria, using 3-5 clinical 
notes provided for a patient, and determine if the patient meets, does not meet, each criterion. 
The organizers have developed the eligibility criteria based on real clinical trials. The criteria 
included patients’ medications, past medical histories, and whether certain events have occurred 
in a specified timeframe in the patients’ records. 
 
The selection criteria for matching patients to a clinical trial is often complex, as it was pointed 
out by the organizers of the shared task. For example, one of the criteria for “Advanced-CAD” is 
“Taking two or more medications to treat CAD”.  It involves three steps – knowing CAD 
medication (brand and generic) names, recognizing the patient is presently taking them, and the 
reason for the medications was to treat CAD not simply for prevention.  There were also other 
complexities such as in “patient speaks English”, the language status is rarely discussed in clinical 
notes and therefore must be inferred from mention of the presence of an interpreter.  
 
The NLP system described here was developed to address the complexities of the shared task 
and to participate in the challenge.  Our system was statistically tied for the first place (along with 
7 others) out of 45 participants. Subsequent to the challenge, noticing the importance of the 
knowledge-resources accuracy, we developed a novel, automated process of curating knowledge 
resources. It enabled the system to improve performance (even though the headroom was small 
to begin with) and achieved numerically the highest performance. In addition, the automated 
process was greatly beneficial in reducing complexity and time to develop the methods (E.g. 
“Alcohol Abuse” originally consisted of painstaking hand-crafting of lexicon; with this system we 
were able to rapidly generate a lexicon and rely solely on it for good results). Even more 
significantly, the resource curation approach is useful beyond this cohort selection task, 
especially to phenotype extraction and classification tasks. 
Methods 
We approached each of the thirteen cohort-selection criteria individually, with either a rule-
based or a supervised learning approach, and often used word-embeddings (unsupervised 
training of word representations) to enhance lexicons. For all criteria, we started with a rule-
based approach but for some either the complexity of the rules or performance was the impetus 
to convert the rules into features and use a supervised learning model. In some cases, after 
building both methods, we chose the rules due to better performance. The supervised learning 
methods were trained using the gold standard provided. 
Cohort Selection Criteria 
As shown in Table 1, the thirteen cohort-selection criteria are wide ranging. They involve lab test 
results, present medical problems, past medical history, current treatments and the reason for 
the treatments, use of over the counter medications, drugs/alcohol consumption, and language 
spoken. 
 
Table 1. Thirteen cohort selection criteria that were defined in the N2C2 Task 1 challenge. 
Num. Short Names  Description 
1 Drug Abuse Drug abuse, past or present 
2 Alcohol Abuse Current alcohol use over weekly recommended limits 
3 English Patient (predominantly) speaks English 
4 Makes-Decisions Patient makes their own medical decisions 
5 Abdominal History of intra-abdominal surgery, small or large intestine 
resection or small bowel obstruction 
6 Major-Diabetes Any of the following that are a result of (or strongly correlated 
with) uncontrolled diabetes: Amputation, Kidney damage, 
Skin conditions, Retinopathy, Nephropathy, or Neuropathy 
7 Advanced-CAD Advanced cardiovascular disease having two or more of: 
• Taking two or more medications to treat CAD 
• History of myocardial infarction 
• Currently experiencing angina 
• Ischemia, past or present 
8 MI-6Months Myocardial infarction in the past 6 months 
9 Keto-1Yr Diagnosis of ketoacidosis in the past year 
10 DietSupp-2Months Supplements (excluding Vitamin D) in the past 2 months 
11 ASP-for-MI Use of aspirin to prevent myocardial infarction 
12 HBA1c (high) Any HbA1c value between 6.5 and 9.5% 
13 (Elevated) Creatinine Serum Creatinine > normal upper limit 
 
Dataset 
The dataset consisted of 3 to 5 for clinical notes for each patient, which are ordered in time but 
they are not necessarily consecutive. Clinical notes had date and time stamps which were 
systematically shifted into future by a (patient-specific) random amount of time. The date of the 
latest clinical note was to be considered as the present day for temporal criteria or sub-criteria. 
The training set consisted of clinical notes for 202 patients. Each patient record was annotated 
with patient level tags indicating if the patient “met” or “not met” each of the 13 criteria. Clinical 
notes of ten of the patients were further annotated with (non-exhaustive) detailed evidence of 
the patient-level annotation. For example, if a patient in this smaller set were to have MI in the 
past 6 months, a specific sentence indicating the fact was annotated as detailed evidence. The 
test set consisted of 3-5 clinical notes for additional unannotated 86 patients, which was released 
a couple of days before the deadline for results submission.  
 
Basic biomedical NLP processing 
As a first step we processed each clinical note in the dataset using the CLAMP biomedical NLP 
software [5] with the built-in “NER-attribute” pipeline. In addition to tokenization and sentence 
segmentation, it provided medical named entity recognition, entity mapping to standard medical 
coding systems (e.g. SNOMED and RxNORM), section identification, and assertions such as 
presence and negation. Most but not all of our analytics leveraged the output of this 
preprocessing step. 
 
General framework  
For each criterion and sub-criterion there were three steps in developing the method for it: 
1. Determine knowledge resources needed and build them using available information from 
the Web or via sampling the pre-trained biomedical word2vec model as criterion-specific 
lexicons (e.g. names of the drugs used to treat CAD); 
2. Develop a rule-based method to determine if the patient meets the criterion or sub-
criterion or not (e.g. Identify occurrences of the CAD drugs in a patient’s clinical notes) 
3. Ensure additional constraints are considered (e.g. the patient is indeed taking the drugs, 
i.e. not negated nor hypothetical, and that the drugs prescribed for CAD for the patient). 
For each such method, there were multiple iterations of fine-tuning rules (using the training data) 
and when the rules became too complex, the rules were replaced with a supervised learning 
model, which were tuned via cross-validation performed on the training data. Even more 
importantly, there was a significant effort to improve the accuracy of the knowledge resources, 
which was initially done through trial and error and was later refined into a systematic, 
automated method that will be described below. The knowledge resources were lists of words 
or phrases, and therefore in the linguistic sense they were task-specific lexicons. The draft 
versions of the lexicons were obtained from the Web or manually created, and then the 
word2vec model pre-trained on biomedical text [6] was used for expanding it with similar words 
and phrases. The overall system schematic is shown in Figure 1. 
 
 
Figure 1. A schematic of our overall system for cohort selection. 
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Methods for Each Criterion 
Drug-Abuse: BioNLP preprocessing (CLAMP) output was used for this criterion in order to extract 
entities from the text that were “problem” or “drug” entities, and to determine if these entities 
were mentioned in the patient history section. A small list of normally abused drugs (lexicon) was 
manually constructed from searching the Web, and the drug mentions were matched with the 
list. Rules checked to ensure the drugs were not prescribed using a heuristic that the presence of 
dosage of the drug implies prescribed use. CLAMP’s assertion identifier was also used to rule out 
negated mentions of phrases indicating drug abuse, which accurately asserted whether the 
criterion was met or not met. The complexity with this criterion was threading the needle 
between identifying whether the mentioned drugs were abused or prescribed; this was 
accomplished through a combination of drug dosage detection and assertion detection (using 
CLAMP) along with regex rules. 
 
Alcohol-Abuse: Various expressions, relating to alcohol abuse, binge drinking, or alcohol abuse-
related terms such as ‘AA’ (Alcoholic Anonymous), were constructed as rules using manually 
curated lexicon; their presence indicated “met”. One interesting component of this criteria was 
determining what would constitute “abuse” — in particular, mention of another family member 
expressing concern about the patient’s drinking was a good indicator of abuse, and thus was used 
in rules. Additional temporal constraints were used in the rules to disqualify mentions of abuse 
that clearly occurred in the past or that had been stopped. CLAMP output was not needed in the 
method for this criterion. 
English speaking: A list of languages was obtained from an online source (http:// 
aboutworldlanguages.com/languages-a-z), and text search was conducted for occurrences of 
language mentions other than English, in combination with words/phrases indicating spoken 
language; the heuristic was that a match indicated this criterion was not met. Additionally, a text 
search for the mention of an interpreter was conducted; if found (considering possible negation), 
the criteria was not met. We trained a machine learning model with the aforementioned factors 
as features, but there was no performance improvement. This criterion was presumed to be 
“met” by default, and only changed to “not met” in the presence of the information mentioned 
above. 
 
Makes Decisions: A Naive Bayes classifier was trained and cross-validated on the training set. 
Features were the number of times each of the following regex (in python syntax) occurred in 
the raw text: 
/dementia/ 
/(?<!psychomotor )retard/  
/(altered mental|mental stat)/ 
The first regex obviously matches the sequence dementia; the second matches occurrences of 
retard that does not follow psychomotor; and the last regex matches altered mental or mental 
stat patterns. We assumed not-met unless the model returns a score above a high threshold 
(determined heuristically). 
 
Abdominal: CLAMP output was used to obtain medical problems mentioned in the “Past Medical 
History” and “History of Present Illness” sections. These extracted problems were matched with 
a dictionary consisting of terms indicating abdominal surgeries and bowel obstruction. The 
dictionary (the lexicon) was compiled manually by curating names of common surgical 
procedures from Wikipedia. We learned (from the training data) that some procedures, such as 
'aortic valve replacement’, although not generally thought of as abdomen related, involve 
surgery that falls under the criterion, and hence was added to the lexicon.  
 
Major-Diabetes: For this criterion, we used medical concepts which were tagged as problem and 
treatment by the BioNLP preprocessing software. A support vector machine-based classification 
model was trained. Count of terms in the patient record that indicate the following clinical 
characteristics of patients which are not in the family history section were used as features in the 
model:  
1. bad skin conditions 
2. kidney damage  
3. neuropathy  
4. nephropathy  
5. retinopathy  
Terms (lexicons) related to bad skin conditions, kidney damage, neuropathy, nephropathy, and 
retinopathy were curated using Google and pre-trained biomedical embeddings. 
 
Advanced-CAD: We used CLAMP output for drugs, problems, and assertions on them in the 
patient record, and to exclude entities in the social history. Rules were used to test for: 
• Presence of ischemia (assertion states “present”); 
• MI-related words (assertion states “present”); 
• Angina and angina-related terms in the most recent clinical note and assertion states 
“present”; and 
• Presence of (two or more) medications for CAD and that the patient has CAD.  
The CAD-Medication list was manually curated from online angina medications list [7] from 
Healthline, and from general CAD information and medications [8], beta-blockers [9], and ACE-
inhibitors [10] from the online WebMD pages. An important consideration was that even if angina 
was mentioned to be present in the recent clinical note, if it was later negated then the final 
decision should be “not met” for the “currently experiencing angina” sub-criterion. 
 
MI-6Months: The 'section' tags and medical problems from the CLAMP output were used. 
Synonymous MI terms such as "NSTEMI", "STEMI", "NQWMI", "IMI", "myocardial", and 
"myocardial infarction” were manually curated and used to determine if patient had MI. Negated 
mentions and mentions in the past medical history section were discarded. The timestamps on 
the clinical notes were once source of the temporal assertion on the MI mentions. Another source 
was the mentions of temporal events such as “9 months ago” in the sentence containing the MI 
term. HeidelTime [11] was used for interpreting time labels in a consistent way, however, further 
specialization was needed with partial date specification such as "3/78". 
 
Keto-1Yr: This was not present in the entire training set and so we created simple rules to test 
for the presence of “ketoacidosis” (its variants) as a disease and/or positive urine-ketones test 
(and its variants). Later, we learned that there was not a positive example in the test dataset 
either. 
 
DietSupp-2Months: A resource of generic names and brand names of dietary supplements was 
developed using resources from MedlinePlus [12]. The named entities of types treatments and 
medications from the CLAMP output were checked against it using two-way substring matching 
after conversion to all lower case. The two-way substring matching returns true if s1 is a 
substring of s2 or vice-versa. 
 
ASP-for-MI: For this category the CLAMP output was used to identify terms which the software 
identified as a problem, a treatment, or a drug.  A Decision Tree based classification model 
performed better than a logistic regression or SVM for this task. The following features were used 
in the classification model:  
1. If the patient was prescribed Aspirin or not: This was determined by searching for aspirin and 
other medical names of aspirin (such as ASP) in the CLAMP output for drugs and treatments. 
2. Dosage of the prescribed Aspirin (or its variants). 
3. If the patient was diagnosed with MI or not: This feature was also determined by searching 
for not only MI but also for medical synonyms of MI in the CLAMP output. 
4. Whether the patient had symptoms indicating MI: The terms indicating the symptoms were 
compiled using an initial lexicon manually curated from online sources and later expanded 
as below. 
The lexicons for Aspirin, MI, and MI symptoms were expanded using pre-trained biomedical 
word2vec model [6] and manual inspection.  
 
HBA1C (high): The biomedical NLP pre-processing software, CLAMP, was used to extract 
keywords which were tagged as either lab tests or lab values.  A support vector machine 
classification model performed best in determining whether the input document satisfies the 
HBA1c criteria or not. The following features were extracted from the CLAMP output using 
regular expressions for this model: 
1. Presence of keywords related to hemoglobin in the document: The keywords similar to 
hemoglobin were retrieved from the pre-trained Google embeddings from newswire 
articles [13] and (separately) from the embeddings from biomedical text [6]. 
2. Presence of a lab value corresponding to keywords related to hemoglobin.  
3. Range of the lab values associated with hemoglobin or similar terms: Range was extracted 
from the text tagged as lab value using regular expressions.  
 
(Elevated) Creatinine: Regular expressions and rules were used with the following arguments: 
1. Elevated Creatinine or words similar to it were present in the clinical notes; 
2. Lab test values (either listed as a series of lab name and value pairs, or in a table format, 
or mentioned in the text); 
3. Applying the range given in the clinical note to creatinine values in the note, otherwise 
applying the generally accepted normal ranges (see below); and 
4. Ignoring creatinine levels taken from urine analysis. 
According to Wikipedia, generally acceptable normal levels of creatinine in the blood are 0.6 to 
1.2 milligrams per deciliter (DL) in adult males and 0.5 to 1.1 milligrams per deciliter in adult 
females. In our rules, the criterion was “not met” if the values were in the normal range specified 
in the clinical note or within general normal range plus 0.5 (to account for the variability in what 
is generally considered “normal”); otherwise the criterion was “met”. Neither external resources 
nor CLAMP output were used. 
 
A Novel Approach for Lexicon Curation 
As can be seen from the description of the methods above, there was a frequent need for task-
specific lexicon, a knowledge resource. Although we used manual curation for the Challenge (due 
to the time constraints), it became obvious to us that there was a critical need for a standardized 
and automated process. Therefore, after the Challenge, we turned our attention to developing 
such method to obtain task specific lexicons, for use in rule- or classifier-based solutions in 
general. The resulting novel approach consists of the following steps: 
1. Create n-grams (up to n=4) from the training data; use these as features in a logistic 
regression model; 
2. Train and test the logistic regression model using 5-fold cross-validation on the training set; 
store average coefficient weights corresponding to each “feature” (n-gram) from the models; 
3. From the model (averaged over cross-validation steps), identify n-grams corresponding to the 
most positive and negative coefficients; We hypothesized that these are the most 
discriminative features. Keep the n-grams whose absolute coefficients are above a threshold 
(which is also learned through cross-validation);   
4. Augment this vocabulary with terms within a small similarity distance (determined by trial 
and error) to n-grams obtained in step 3 above in a pre-trained word2vec model on 
biomedical text [6]; iterate upon terms for a few times (also determined heuristically) to 
expand the list further; 
5. Use the combination of logistic regression-obtained and word2vec-obtained terms as the 
lexicon in rules- or classifier-based system; and  
6. If wanting to expand/narrow vocabulary, carry out steps 1-5 with differing thresholds for the 
coefficient values in step 3 and the similarity distance in the word embeddings in step 4. 
This system represents lexicon selection from data within the training set (internally cross-
validated on the training dataset) and from related data outside the training set to catch any 
similar terms that may not be in the training set but are still useful (i.e. externally enhanced using 
word embedding pre-trained on related corpora). We refer to this system as the Internal plus 
External Lexicon Selection (IELS) method. It should be noted that this approach not only selects 
single words (unigrams) but also multi-word phrases (n-grams) which are often common in 
biomedical text. This approach is a variant of well-known dimensionality reduction methods such 
as PCA (Principal Component Analysis), PMI (Point-wise mutual information) based feature 
selection, and LASSO (L1 regularized least squares regression). We applied this approach in 
rebuilding lexicons for a few of the criteria. 
Performance metrics 
Accuracy of the system was measured for each criterion as well as together for all criteria. 
Standard precision (P), recall (R), F measure, and Area under the precision-recall curve (AUC) 
were used. Every decision made by the system for each criterion was scored as one of True 
Positive, True Negative, False Positive, or False Negative (i.e. no multiple counting of errors). For 
the aggregate measure, both micro and macro average were calculated. The scripts provided by 
the Challenge organizers were used in reporting the metrics.  
Table 2. Performance accuracy of our system as submitted to the N2C2 Challenge 
 
Results 
Table 2 shows accuracy metrics for the system that was submitted to the Challenge. The overall 
micro accuracy was 0.9003 and AUC was 0.9005. The test data is highly skewed, for example, 
Alcohol abuse, Drug abuse, Keti-1Yr, and MI-6mos have less than 7 positive cases, and Makes-
Decisions has only 3 negative instances. Therefore, the F measure for the individual criteria varied 
in a wide range from 0.4881 to 0.9247. Excluding these skewed criteria, F measure was in a tighter 
range of 0.8303 to 0.9247 (except for ASP-for-MI, which was 0.6475), indicating a good balance 
of performance among our methods.  
 
Table 3 shows changes in the micro-averaged F measure with the systematic lexicon curation for 
Major-Diabetes, Drug-abuse, and Alcohol-abuse.  The goal of this approach is a systematic 
methodology to otherwise laborious and error-prone lexicon curation and therefore small or no 
improvement in accuracy is acceptable. Further studies are needed to test its effectiveness.  
Table 3. Changes in accuracy with the model-based lexicon curation 
 
Table 4 shows improved accuracy metrics for the system after the Challenge. The improvements 
were achieved using the systematic lexicon creation for the three criteria as well as debugging of 
Criterion F Measure
With manual 
curation
With the 
model-based 
curation
Major-Diabetes 08350 0.8350
Drug-abuse 0.8273 0.8273
Alcohol-abuse 0.4881 0.4911
the code and regular expressions (only using the training data). Improvement was seen in 
Advanced-CAD, Alcohol-abuse, Creatinine, and MI-6months. These changes resulted in the 
improvement of the overall micro-averaged F measure to 0.9140 and the overall AUC to 0.9139. 
Numerically, the overall F measure is better than the best score at the Challenge. The top overall 
F measures along with our new accuracy score are shown in Table 5. 
Table 4. Performance accuracy of our system with improvements after the Challenge. 
 
Discussion 
Cohort selection is similar to phenotype extraction and classification, since as described in a 
review [14] of approaches to identifying phenotype cohorts using electronic health records, 
phenotype may be broadly defined as the observable 
characteristic of a patient. The review concluded that the 
majority of the studies used rules and regular expressions, 
for simplicity as well as for their effectiveness. We noticed 
the same in developing our own system. In previous 
studies, typically the rules were developed based on 
clinician description and judgement as in the system [15] 
that analyzed discrete data and HL7 text messages for 
identifying eligible patients for cancer trials. Some studies 
developed rules from guidelines (for example, to screen 
patients at risk for type 2 diabetes [16]) or refined existing 
rules. In our case, we used the annotation guidelines 
provided by the Challenge and our own understanding of 
the criteria, based on the online and text book knowledge, 
to build and refine the rules. 
 
Several off-the-shelf biomedical NLP systems such as 
cTAKES [17], MedLEE [18], and Metamap [19] are available 
to identify key medical concepts from clinical text. An 
earlier study [20] even went one step further and tried to 
extract relevant sentences from clinical notes given clinical 
Table 5. Results for the top ten teams at the 
challenge (shaded entries statistically tied for 
the 1st place) and our post-submission accuracy. 
Team name Overall micro 
F measure
Arizona State University 
(post-submission) 0.9140
MedUniGraz 0.9100
University of Michigan 0.9075
Sorbonne Universite 0.9069
Med Data Quest 0.9028
Cincinnati Children’s 
Hospital Medical Center 0.9026
Arizona State University 
(original submission) 0.9003
University of NSW / 
National Cancer Institute 0.8913
Harbin Institute of 
Technology 0.8855
University of Utah 0.8837
NTTMUNSW 0.8765
trial eligibility (using the same dataset that was used here from an earlier challenge), with the 
expectation that these sentences help narrow the scope of the rules. But the accuracy was low. 
We found that CLAMP [5] met our requirements well in terms of providing the necessary 
concepts, assertions, and section tags, and thus allowed us to focus on criterion-specific logic and 
lexicons. 
 
The TREC medical record track conducted challenges for cohort selection in 2011 and 2012 as 
information retrieval (IR) tasks [21]. Because the goal was to find the most relevant documents 
(e.g. clinical notes), the task and performance of the participating systems are not comparable to 
our system or this task. However, an analysis of the barriers in retrieving relevant information 
from patient records [22] and the use of the physician judgements to learn relevance models [23] 
are in general relevant to cohort selection from patient records. 
 
In the present cohort selection challenge, a total of 45 teams participated, and most of the top-
performing systems predominantly used rules, regular expressions, and off-the-shelf concept 
extraction biomedical software (https://portal.dbmi.hms.harvard.edu/projects/n2c2-t1/). 
However, the systems did make use of simple learning systems for narrow purposes. In fact, 
systems that exclusively relied on learning methods performed poorly, indicating the need for 
fine tuning the analytics in this task and the limited size of the training and test sets. Our general 
approach is therefore similar to the other top performing systems, however, we emphasize the 
use and development of lexicon because of its importance in cohort selection.  
Conclusion 
This paper reported a system we developed for the N2C2 cohort selection shared challenge and 
our system was statistically tied for the first place along with 7 other systems among a total of 45 
participants. We took a divide and conquer approach by developing separate analytics for each 
of the 13 criteria for cohort selection. The methods usually but not always used the output of a 
biomedical preprocessing software, CLAMP, such as medical concepts, asserts, and section tags. 
Most analytics used rules and regular expressions but three analytics used supervised learning 
(SVM and decision trees). All of them critically depended on knowledge resources in the form of 
lexicons relevant to the criteria. Therefore, subsequent to the challenge we developed a 
supervised learning model-based approach to curating lexicons. The key benefit of this approach 
is to automate and standardize the curation process. Additional tuning of the rules resulted in 
performance that is numerically higher than the best performance from the Challenge. A 
challenge for the future is to develop automatic methods that integrate domain knowledge (that 
are now used in manual creation of rules) with machine learning methods. 
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